PERSPECTIVE THERAPEUTICS, INC. Retained Earnings
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Retained Earnings of -$387.81 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-10
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$387.81M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$361.03M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$334.84M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$297.35M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$387.81M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$361.03M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | -$334.84M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | -$297.35M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$271.38M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$249.90M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | -$231.72M 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$191.55M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$176.43M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$164.72M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$152.44M 10-K/A · filed 2025-03-28 | |
| 2023-09-30 | -$127.77M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$117.41M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | -$106.30M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$105.93M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$102.67M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$98.60M 10-KT · filed 2023-05-01 | |
| 2022-03-31 | -$96.52M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$95.17M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | -$93.57M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$91.33M 10-KT · filed 2023-05-01 | |
| 2021-03-31 | -$90.26M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$89.52M 10-Q · filed 2021-02-09 | |
| 2020-09-30 | -$88.65M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | -$87.94M 10-K · filed 2021-09-27 | |
| 2020-03-31 | -$86.75M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | -$86.20M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | -$85.31M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$84.49M 10-K · filed 2020-09-25 | |
| 2019-03-31 | -$83.40M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | -$82.27M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | -$80.86M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$79.35M 10-K · filed 2019-09-27 | |
| 2018-03-31 | -$76.95M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | -$75.61M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | -$74.15M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$72.60M 10-K · filed 2018-09-26 | |
| 2017-03-31 | -$70.75M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$69.39M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | -$67.94M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$66.44M 10-K · filed 2017-09-28 | -$66.44M 10-K · filed 2016-09-09 |
| 2016-03-31 | -$65.26M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$64.06M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | -$62.75M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$61.73M 10-K · filed 2016-09-09 | |
| 2015-03-31 | -$60.70M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$59.74M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | -$58.84M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$58.05M 10-K · filed 2015-09-14 | |
| 2014-03-31 | -$56.37M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$54.29M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$53.36M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$52.09M 10-K · filed 2014-09-29 | |
| 2013-03-31 | -$51.10M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$50.38M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | -$49.23M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$48.23M 10-K · filed 2013-09-30 | |
| 2012-03-31 | -$47.03M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$46.48M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$45.85M 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | -$44.75M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |